In win for animals, the FDA takes new steps away from animal testing

The FDA plans to update its drug regulations to remove references to mandatory animal testing, clarifying that companies can use non-animal methods like organ-on-a-chip and AI simulations for drug approval. This regulatory change aims to reduce animal testing in pharmaceuticals, with significant global implications given the U.S. market size.

This Wire brief sits within Fusion42's coverage of Biotech.